当前位置: 首页 > 详情页

Identification of hub genes and pathways in glioblastoma by bioinformatics analysis

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Neuro-Οncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050 [2]Continuing Education and Training Department, Beijing Rehabilitation Hospital Affiliated to Capital Medical University,Beijing 100144, P.R. China
出处:
ISSN:

关键词: glioblastoma bioinformatics analysis protein-protein interaction pathway analysis module analysis

摘要:
Glioblastoma (GBM) is the most common type of malignant brain tumor, and is associated with poor patient prognosis. A comprehensive understanding of the molecular mechanism underlying GBM may help to guide the identification of novel diagnoses and treatment targets. The gene expression profile of the GSE4290 GBM dataset was analyzed in order to identify differentially expressed genes (DEGs). Enriched pathways were identified through Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes analyses. A protein-protein interaction network was constructed in order to identify hub genes and for module analysis. Expression and survival analyses were conducted in order to screen and validate critical genes. A total of 1,801 DEGs were recorded, including 620 upregulated and 1,181 downregulated genes. Upregulated DEGs were enriched in the terms mitotic cell cycle process', mitotic cell cycle' and cell cycle process'. Downregulated genes were enriched in transsynaptic signaling', anterograde transsynaptic signaling' and synaptic signaling'. A total of 15 hub genes, which displayed a high degree of connectivity, were selected. These genes included vascular endothelial growth factor A, cyclin-dependent kinase 1 (CDK1), cell-division cycle protein 20 (CDC20), aurora kinase A (AURKA), and budding uninhibited by benzimidazoles 1 (BUB1). The identified DEGs and hub genes may help guide investigations on the mechanisms underlying the development and progression of GBM. CDK1, CDC20, AURKA and BUB1, which are involved in cell cycle pathways, may be potential targets in the diagnosis and therapy of GBM.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2017]版:
Q4 ONCOLOGY
最新[2023]版:
Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Neuro-Οncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050
共同第一作者:
通讯作者:
通讯机构: [1]Department of Neuro-Οncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050 [*1]Department of Neuro-Oncology, Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, 6 Beijing Tiantan Xili, Beijing 100050, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院